The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (15 analysts) rates it buy, with a mean price target of $120.
Ameren
AEE · a US exchange · USD · Market cap $29.4B · 8,913 employees
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Ameren holds its Markdown at $106.25. The statistical read favours the sellers, held for 11 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 11 days |
| Price at the screen | $106.25 |
| Valuation | 18.71 trailing · 18.29 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.47 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 40.91% | Below 33% | Interest-bearing debt is 40.9% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 1.40% | Below 49% | Money owed to the company is 1.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.47% | Below 5% | Only 0.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $87.85 fair value estimate, moderate competitive moat.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 17.3% above the base estimate.
Third-party analyst targets: 15 covering, consensus None. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSteady utility but debt and price block the way
Utilities are sold as the calm option when markets turn choppy, yet Ameren sits 17 percent above our fair value at 111 dollars versus 93. Forward earnings sit at 19 times while revenue edges up just 4 percent a year and return on equity reaches only 12 percent. That combination leaves little margin for the surprises that always hit regulated networks.
The moderate moat and 18 percent profit margin look respectable on paper, but they do not offset the stretched valuation or the fact that fifteen analysts still push a 121 dollar target. We pass because the numbers simply do not line up with the price on offer.
On top of the valuation gap the company fails our ethical screen on its debt ratio. That screen exists for a reason and we follow it. Analysis, not advice.
| Forward P/E | 18.3xreasonably valued |
| Trailing P/E | 18.7xreasonably valued |
| EPS, trailing | 5.68 |
| EPS, forward | 5.81 |
| Revenue growth | -6.2%revenue is shrinking |
| Profit margin | 18.6%healthy profit margins |
| Return on equity | 11.9%a modest return on shareholder capital |
| FCF yield | -6.07% |
| Dividend yield | 275.00% |
| Debt to equity | 1.58a meaningful debt load worth watching |
| Current ratio | 0.53below 1: short-term bills exceed liquid assets |
| Beta | 0.47barely tracks the market's swings |
| Short interest, float | 0.05% |
| 52-week range | 96.57 - 118.32 |
| Moat | MODERATE |
| Market cap | $29.4B |
| Employees | 8,913 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeAEE trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (15 analysts) rates it buy, with a mean price target of $120.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (15 analysts) rates it buy, with a mean price target of $120.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (15 analysts) rates it buy, with a mean price target of $120.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 4 Utility Electric Power Stocks to Buy Amid Industry Headwinds Zacks · 17 Jul 2026
- Can FirstEnergy's Grid Investments Drive Long-Term Earnings Growth? Zacks · 16 Jul 2026
- Are Utilities Stocks Lagging Ameren (AEE) This Year? Zacks · 16 Jul 2026
- Here's Why Investors Should Add NI to Their Portfolio Right Now Zacks · 15 Jul 2026
- PPL Stock Trading at a Premium to Industry at 17.74X: Should You Buy? Zacks · 14 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | SHAW THERESA A | Officer | 1,825 | $199,476 | |
| 2026-05-01 | MOEHN MICHAEL L | Officer | 6,500 | $738,595 | |
| 2026-03-05 | BRUNE CATHERINE S | Director | 450 | · | |
| 2026-03-03 | LYONS MARTIN J JR | Chief Executive Officer | 26,818 | $2,999,325 | |
| 2026-03-03 | LINDGREN MARK C | Officer of Subsidiary Company | 2,073 | $231,844 | |
| 2026-03-03 | SCHUKAR SHAWN E | Officer of Subsidiary Company | 4,975 | $556,404 | |
| 2026-02-27 | RAUSCH TIMOTHY S. | Director | 1,251 | · | |
| 2026-02-17 | MIZELL GWENDOLYN G. | Officer of Subsidiary Company | 3,548 | $393,473 | |
| 2026-02-17 | SHAW THERESA A | Officer | 325 | $36,364 | |
| 2026-02-17 | ARORA AJAY K | Officer | 3,000 | $334,320 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 23 Sept2025 | Julie Johnson | Democrat | sell | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | buy | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | sell | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $109.22 | -0.1% | $0.75 | $1,005 | +0.5% |
| 2 months | $112.66 | -3.2% | $0.75 | $975 | -2.5% |
| 3 months | $109.23 | -0.2% | $0.75 | $1,005 | +0.5% |
| 6 months | $95.92 | +13.7% | $1.50 | $1,153 | +15.3% |
| 1 year | $92.99 | +17.3% | $3.63 | $1,212 | +21.2% |
| 2 years | $66.84 | +63.2% | $6.35 | $1,727 | +72.7% |
| 3 years | $75.41 | +44.6% | $8.91 | $1,564 | +56.4% |
| 5 years | $74.09 | +47.2% | $13.00 | $1,648 | +64.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever AEE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.